Healionics Corporation, a private medical device company, has announced the completion of a $4.7M equity financing round led by Keiretsu Capital. The company also announced the conversion to equity of $5.2M in previously outstanding notes and interest. Healionics is preparing to commercialize its innovative STARgraft vascular graft. “We appreciate the strong support in this round by existing shareholders and welcome the participation by…